Category Archives: R&D
Source: All India Drug Action Network (AIDAN) The Department of Pharmaceuticals has circulated a Draft Pharmaceutical Policy, 2017 which can be accessed here. The draft policy identifies the following key objectives: a. Making essential drugs accessible at affordable prices to the … Continue reading
International Trade and Economic Development division of South African Government has released the Draft Intellectual Property Policy of the Republic of south Africa Phase 2017 and it is now publicly available for comments. Access the draft policy here: http://www.dti.gov.za/gazzettes/IP_Policy.pdf
Source: New York Times How’s this for a great deal? The United States government funded research and development of a new vaccine against Zika. But the Army, which paid a French pharmaceutical manufacturer for its development, is planning to grant exclusive … Continue reading
Lawmakers are concerned that giving a drug company a monopoly on the promising vaccine could make it unaffordable.
US Supreme Court Adopts International Exhaustion For Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices
By Frederick M Abbott*, IP Watch | 31/05/2017 The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v. Lexmark International, No. 15-1189. … Continue reading